Brief: Aker BioMarine Q1 Adj. EBITDA at USD 6 Million
28/04/2023 06:05
Apr 28 (Reuters) - Aker BioMarine Q1 adjusted EBITDA USD 6 million. * Q1 revenue USD 69 million * Expects long-term average annual sales growth in line with earlier communicated ambitions at around 15%
Recent news on Aker Biomarine ASA
See all newsBrief: Aker ASA: Conditions For Completion Of Merger With Aker Biomarine Satisfied
Brief: Aker Capital Buys 933,110 Aker BioMarine Shares
Brief: Aker Biomarine To Hold EGM On August 17
Brief: Aker Biomarine: Optional Cash Offer To Shareholders
Brief: Aker Biomarine: Proposed Merger And Optional Cash Offer